Skip to contentC
Cerenome, Inc.
C
CNSYCerenome, Inc. Q1 2020 · 10-Q
Revenue—
Net Income-$1.09M-$1.09MN/M vs Q1 2019 EPS Diluted-$0.28-$0.28N/M vs Q1 2019 Operating Income-$2,441,000N/M Operating Cash Flow-$1,502,000N/M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cerenome, Inc. · CIK 1095981 · Engraved from SEC EDGAR
Free Cash Flowderived-$1,513,000N/M ended Mar 31, 2020 · filed May 14, 2020 · 44 d after period end